Starling Oncology, Inc. (STLN) stock
STLNNasdaqServices-Offices & Clinics of Doctors of MedicineFiscal year ends December 31Also trades as DFPH, STLNW
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 7/30
$3.20−0.20 (-5.88%)
Close on Nov 18, 2026Market cap $326.13MP/E –Yield –
Starling Oncology total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Starling Oncology's total debt was $72.52M at Sep 30, 2026. For fiscal 2025 it was $77.40M, down 16.9% from the year before. The highest annual figure on record is $93.13M in fiscal 2024.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $77.40M | -16.9% |
| FY2024 | Dec 31, 2024 | $93.13M | +7.3% |
| FY2023 | Dec 31, 2023 | $86.83M | +7.7% |
| FY2022 | Dec 31, 2022 | $80.62M | +43955.2% |
| FY2021 | Dec 31, 2021 | $183.00K | -98.5% |
| FY2020 | Dec 31, 2020 | $11.93M | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $72.52M | -4.8% |
| Q2 FY2026 | Jun 30, 2026 | $79.87M | +6.5% |
| Q1 FY2026 | Mar 31, 2026 | $78.61M | +6.4% |
| Q4 FY2025 | Dec 31, 2025 | $77.40M | -16.9% |
| Q3 FY2025 | Sep 30, 2025 | $76.20M | -16.8% |
| Q2 FY2025 | Jun 30, 2025 | $75.02M | -16.6% |
| Q1 FY2025 | Mar 31, 2025 | $73.89M | -16.4% |
| Q4 FY2024 | Dec 31, 2024 | $93.13M | +7.3% |
| Q3 FY2024 | Sep 30, 2024 | $91.54M | +7.4% |
| Q2 FY2024 | Jun 30, 2024 | $89.95M | +7.5% |
| Q1 FY2024 | Mar 31, 2024 | $88.39M | +7.6% |
| Q4 FY2023 | Dec 31, 2023 | $86.83M | +7.7% |
| Q3 FY2023 | Sep 30, 2023 | $85.25M | +7.8% |
| Q2 FY2023 | Jun 30, 2023 | $83.69M | – |
| Q1 FY2023 | Mar 31, 2023 | $82.14M | – |
| Q4 FY2022 | Dec 31, 2022 | $80.62M | +43955.2% |
| Q3 FY2022 | Sep 30, 2022 | $79.07M | +562.8% |
| Q2 FY2022 | Jun 30, 2022 | $0 | – |
| Q1 FY2022 | Mar 31, 2022 | $0 | – |
| Q4 FY2021 | Dec 31, 2021 | $183.00K | – |
| Q4 FY2020 | Dec 31, 2020 | $11.93M | – |
See a number that looks wrong?